This action makes these agents a therapeutic option for weight loss.56 Although to a lesser extent, delay in gastric emptying contributes to the anorexigenic effect.61 Clinical trials conducted with GLP-1 receptor agonists in patients with obesity (or excess weight [BMI 27] with comorbidities), or with DT2 and excess weight or obesity, have achieved weight reductions greater than those reported for orlistat, as well as those observed with oral antidiabetic agents such as the sodium glucose type 2 cotransporter inhibitors (SGLT2i) or metformin.62 In a meta-analysis of more than 10 000 patients with obesity, those treated with GLP-1 receptor agonists lost, on average, 7kg more than those in the control group.63 Weight loss of up to 15% has been observed after 12 months of treatment,64,65 a level that had only been achieved through surgical methods
You'd prefer a natural peptide treatment, such as GHK-Cu, over more aggressive options
Effect of carnitine supplementation on mitochondrial enzymes in liver and skeletal muscle of rat after dietary lipid manipulation and physical activity
CLINICALLY PROVEN RESULTS 94% had visibly improved discolouration 91% had brighter-looking skin 0% reported irritation* *Based on an independent clinical study with 32 subjects after 8 weeks Find out if this formula works for you
What is compounded tirzepatide, and how is it different from Mounjaro or Zepbound
50% of people in the treatment group lost at least 15% of their body weight over 68 weeks and 86% lost at least 5%
